Literature DB >> 34077782

Escaping the endosome: assessing cellular trafficking mechanisms of non-viral vehicles.

Emily Xu1, W Mark Saltzman2, Alexandra S Piotrowski-Daspit3.   

Abstract

Non-viral vehicles hold therapeutic promise in advancing the delivery of a variety of cargos in vitro and in vivo, including small molecule drugs, biologics, and especially nucleic acids. However, their efficacy at the cellular level is limited by several delivery barriers, with endolysosomal degradation being most significant. The entrapment of vehicles and their cargo in the acidified endosome prevents access to the cytosol, nucleus, and other subcellular compartments. Understanding the factors that contribute to uptake and intracellular trafficking, especially endosomal entrapment and release, is key to overcoming delivery obstacles within cells. In this review, we summarize and compare experimental techniques for assessing the extent of endosomal escape of a variety of non-viral vehicles and describe proposed escape mechanisms for different classes of lipid-, polymer-, and peptide-based delivery agents. Based on this evaluation, we present forward-looking strategies utilizing information gained from mechanistic studies to inform the rational design of efficient delivery vehicles.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Endosomal escape; Nanoparticle; Non-viral vehicle; Polymeric vehicle

Year:  2021        PMID: 34077782     DOI: 10.1016/j.jconrel.2021.05.038

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

Review 1.  Leveraging self-assembled nanobiomaterials for improved cancer immunotherapy.

Authors:  Michael P Vincent; Justin O Navidzadeh; Sharan Bobbala; Evan A Scott
Journal:  Cancer Cell       Date:  2022-02-10       Impact factor: 31.743

2.  Computational Insights into the Role of Cholesterol in Inverted Hexagonal Phase Stabilization and Endosomal Drug Release.

Authors:  Mohsen Ramezanpour; D Peter Tieleman
Journal:  Langmuir       Date:  2022-06-08       Impact factor: 4.331

Review 3.  Overcoming barriers in non-viral gene delivery for neurological applications.

Authors:  Aaron Tasset; Arjun Bellamkonda; Wenliang Wang; Ilya Pyatnitskiy; Deidra Ward; Nicholas Peppas; Huiliang Wang
Journal:  Nanoscale       Date:  2022-03-10       Impact factor: 8.307

4.  Evolution of drug delivery systems: From 1950 to 2020 and beyond.

Authors:  Haesun Park; Andrew Otte; Kinam Park
Journal:  J Control Release       Date:  2021-12-29       Impact factor: 11.467

5.  Cytosolic protein delivery using pH-responsive, charge-reversible lipid nanoparticles.

Authors:  Yusuke Hirai; Hisaaki Hirose; Miki Imanishi; Tomohiro Asai; Shiroh Futaki
Journal:  Sci Rep       Date:  2021-10-06       Impact factor: 4.379

6.  In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA.

Authors:  Ayoub Medjmedj; Albert Ngalle-Loth; Rudy Clemençon; Josef Hamacek; Chantal Pichon; Federico Perche
Journal:  Nanomaterials (Basel)       Date:  2022-07-17       Impact factor: 5.719

Review 7.  mRNA nanomedicine: Design and recent applications.

Authors:  Luke J Kubiatowicz; Animesh Mohapatra; Nishta Krishnan; Ronnie H Fang; Liangfang Zhang
Journal:  Exploration (Beijing)       Date:  2022-09-19

8.  Gelatin Nanoparticles for Complexation and Enhanced Cellular Delivery of mRNA.

Authors:  Lea Andrée; Rik Oude Egberink; Josephine Dodemont; Negar Hassani Besheli; Fang Yang; Roland Brock; Sander C G Leeuwenburgh
Journal:  Nanomaterials (Basel)       Date:  2022-09-29       Impact factor: 5.719

9.  Improvement of mRNA Delivery Efficiency to a T Cell Line by Modulating PEG-Lipid Content and Phospholipid Components of Lipid Nanoparticles.

Authors:  Hiroki Tanaka; Ryo Miyama; Yu Sakurai; Shinya Tamagawa; Yuta Nakai; Kota Tange; Hiroki Yoshioka; Hidetaka Akita
Journal:  Pharmaceutics       Date:  2021-12-06       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.